1 completed, 1 not yet recruiting, 1 recruiting. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 1, Not yet recruiting 1, Recruiting 1 |
| Phase 2 | 1 | Not yet recruiting 1 |
Follow Shingrix®: new trials by email Literature Review of Shingrix® trials Research Report on Shingrix®
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Immunogenicity of the Recombinant Zoster Vaccine, LYB004 in Adults Aged 40 Years and Older Low dose antigen and low dose adjuvant of LYB004, Low dose antigen and high dose adjuvant of LYB004, High dose antigen and low dose adjuvant of LYB004 - Herpes Zoster (HZ) | Phase 1 | Recruiting | Guangzhou Patronus Biotech Co., Ltd. | 92 | 2025-03-13 | 2025-04-01 |
| A Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Recombinant Herpes Zoster Vaccine Recombinant Herpes Zoster Vaccine (SCTV04C) Low-Dose, Recombinant Herpes Zoster Vaccine (SCTV04C) High-Dose, Placebo control: Saline - Herpes Zoster | Phase 1 / Phase 2 | Not yet recruiting | Sinocelltech Ltd. | 540 | 2025-02-15 | 2025-01-30 |
| Safety and Immunogenicity of Recombinant Herpes Zoster Vaccine (CHO Cells) in Healthy Subjects Aged 18 Years and Above Low Dose Recombinant Herpes Zoster Vaccine (CHO cells), High Dose Recombinant Herpes Zoster Vaccine (CHO cells), Low dose adjuvant - Herpes Zoster | Phase 1 | Completed | MAXVAX Biotechnology Limited Liability Company | 132 | 2022-12-07 | 2026-10-15 |
Herpes Zoster (3) · Chickenpox (1)
Guangzhou Patronus Biotech Co., Ltd. (1) · MAXVAX Biotechnology Limited Liability Company (1) · Sinocelltech Ltd. (1)
China (3)
Renfeng Fan (1) · Yanxia Wang (1)